“…Data collection: APEX2 (Bruker, 2007); cell refinement: SAINT (Bruker, 2007); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: SHELXTL (Sheldrick, 2008). (Malyarick et al, 1992), [In(phen)Cl 3 (DMSO)], (VI) (Dong et al, 1987), (Ahmadi et al, 2008), [In(5,5′-dmbipy)Cl 3 (MeOH)], (X) (Abedi et al, 2012b) (bipy = 2,2′-bipyridine, phen = 1,10-phenanthroline, DMSO = dimethyl sulfoxide, 4,4′-dmbipy = 4,4′-dimethyl-2,2′-bipyridine, 5,5′-dmbipy = 5,5′-dimethyl-2,2′-bipyridine, 4,4′-dtbipy = 4,4′-di-tert-butyl-2,2′-bipyridine, 4bt = 4,4′-bithiazole), have been synthesized and characterized by single-crystal X-ray diffraction methods. Di-2-pyridylamine (DPA) is a good bidentate ligand, and numerous complexes with DPA have been prepared, such as that of [Hg(DPA)Br 2 ], (XIV) (Kalateh, Norouzi et al, 2008), [Hg(DPA)Cl 2 ], (XV) (Yousefi et al, 2009), [Pt(DPA)Cl 4 ].DMF, (XVI) (Abedi et al, 2011), [Ir(DPA) 2 Cl 2 ](PF 6 ), (XVII) (Yoshikawa et al, 2004) (Malecki et al, 2011) and [Au(DPA)Cl 2 ]Cl, (XX) (Shi & Jiang, 2006).…”